Stargazer Pharmaceuticals
Latest round
- Series A
Last raised
- Nov 2020
Total raised
- $57M
Investors
- 4
About Stargazer Pharmaceuticals
Stargazer Pharmaceuticals Inc. is a biopharmaceutical company focused on developing innovative therapies to address unmet medical needs.Stargazer Pharmaceuticals Inc. was founded in 2018 in Boston, US, and specializes in the creation of pharmaceutical products.The company offers a diverse range of products designed to meet the needs of its target markets. Central to its offerings is the flagship product, which addresses specific challenges faced by its end users in various industries. The solutions enhance efficiency, streamline operations, and provide valuable insights, leading to improved outcomes for clients. It serves a broad client base that includes both small and large enterprises across multiple sectors, ensuring its innovative solutions cater to a wide array of applications.Revenue generation for Stargazer Pharmaceuticals Inc. is structured around a combination of direct-to-consumer sales and business-to-business partnerships. The transaction model typically involves long-term contracts and subscription services that provide clients with continuous access to the company’s offerings. Companies utilizing the flagship product may engage in annual subscription agreements that ensure ongoing access to updates and support services. Pricing plans are strategically designed to accommodate various client needs, reflecting the value that the company’s products deliver.Stargazer Pharmaceuticals Inc. is actively developing new products aimed at enhancing its therapeutic portfolio, with plans to launch these innovations within the next 12 months. The company is also looking to expand its reach into key international markets, specifically targeting Asia and Europe by 2022.00 mn will be utilized to support these growth initiatives, enabling the company to enhance its research and development capabilities and accelerate its market entry strategies.
Who invested in Stargazer Pharmaceuticals
4 investors across 1 round
See all investors in Stargazer Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Nov 9, 2020
Amount
$57M
Investors
Questions about Stargazer Pharmaceuticals
Who invested in Stargazer Pharmaceuticals?
Stargazer Pharmaceuticals has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Stargazer Pharmaceuticals raised?
Stargazer Pharmaceuticals has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Stargazer Pharmaceuticals last raise money?
Stargazer Pharmaceuticals's most recent round on record is a Series A, in Nov 2020.
What does Stargazer Pharmaceuticals do?
Stargazer Pharmaceuticals is a biotechnology company.
Where is Stargazer Pharmaceuticals headquartered?
Stargazer Pharmaceuticals is headquartered in Boston, US.
Which VCs invest in companies like Stargazer Pharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Stargazer Pharmaceuticals's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Stargazer Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.